Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.

Carolyn Hendricks is a Hematologist Oncology specialist and an Oncologist in Bethesda, Maryland. Dr. Hendricks is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer. She is board certified in American Board Of Internal Medicine.

Surupa Sen Gupta is a General Surgeon and a Surgical Oncologist in Bethesda, Maryland. Dr. Sen Gupta is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Giant Mammary Hamartoma. Dr. Sen Gupta is currently accepting new patients.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia.

"Shannon C. O'Connor, M.D., is a medical oncologist with Suburban Hospital. She practices out of Maryland Oncology Hematology. Dr. O'Connor has expertise in hematology and medical oncology with a special focus in women's health, including breast cancer and gynecologic cancers. Dr. O'Connor earned her Master's Degree in Physiology at Georgetown University, followed by her medical degree from St. George's University School of Medicine. She completed a residency at Washington Hospital Center, as well as a fellowship in hematology and oncology. Dr. O'Connor is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Montgomery County Medical Society and the American Medical Association. Selected Publications Catlett JP1, Williams SA, O'Connor SC, Krishnan J, Malkovska V. ""Primary lymphoma of bone: an institutional experience."" Leuk Lymphoma. 2008 Nov;49(11):2125-32. doi: 10.1080/10428190802404030.". Dr. O'connor is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain.

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.

Daniel Zabransky is an Oncologist in Baltimore, Maryland. Dr. Zabransky is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are HER-2 Positive Breast Cancer, Melanoma, Breast Cancer, and Pancreatic Cancer.

Roy Chisholm is a General Surgeon in Cumberland, Maryland. Dr. Chisholm is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Hernia, Cholecystitis, Gallbladder Disease, Bladder Reconstruction, and Colostomy. Dr. Chisholm is currently accepting new patients.

Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Noeline Rajarajan is a General Surgeon in Baltimore, Maryland. Dr. Rajarajan is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Lump, and Intraductal Papilloma. Dr. Rajarajan is currently accepting new patients.

Kristen Fernandez is a General Surgeon in Baltimore, Maryland. Dr. Fernandez is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Fernandez is currently accepting new patients.

Giuseppe Sanguineti is a Radiation Oncologist in Baltimore, Maryland. Dr. Sanguineti is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are HER-2 Positive Breast Cancer, Prostate Cancer, Throat Cancer, Prostatectomy, and Hepato-Pancreato-Biliary Surgery.

John Wallmark is a Hematologist Oncology provider in Rockville, Maryland. Dr. Wallmark is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Colorectal Cancer.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Najeff Waseem is a Hematologist and a Hematologist Oncology provider in Columbia, Maryland. Dr. Waseem has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Thrombocytopenia, Agranulocytosis, Chronic Familial Neutropenia, and Triple-Negative Breast Cancer.

Nicholas Farrell is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Farrell is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia.